 DEER PARK, Ill., June 15, 2021 GLOBE NEWSWIRE -- Eton Pharmaceuticals, Inc Nasdaq: ETON today announced that the U.S. Food and Drug Administration FDA has approved Rezipres ephedrine hydrochloride injection for the treatment of clinically important hypotension occurring in the setting of anesthesia. 